IDLDX — IDL Diagnostics AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK78.32m
- SEK55.16m
- SEK53.11m
Brief: IDL Diagnostics Q2 EBITDA Loss Narrows To SEK 148,000
Brief: IDL Diagnostics Appoints Gustav Sten As CEO
Brief: IDL Diagnostics Q1 Net Sales SEK 16.7 Million
Brief: Anders Hultman To Step Down As CEO Of IDL Diagnostics
Brief: IDL Diagnostics Q4 EBITDA Swings To Loss SEK 505,000
Brief: IDL Forms Joint Venture With Concile
Brief: IDL Diagnostics Q3 Net Sales Down At Sek 11,378 Thousand
Brief: IDL Receives Order From Japanese Partner For Chinese Market
Brief: IDL Diagnostics Secures Patent Approval In Hong Kong
Brief: IDL Diagnostics Loss After Tax Widens To SEK 14.9 Mln
Brief: Arocell And Concile Sign LoI To Expand Partnership
Brief: Arocell Q1 Net Sales Up At Ksek 15,307
Brief: Arocell Q4 EBITDA Turns To Profit At SEK 964,000
Brief: AroCell Gets New Patent Approval In China
Brief: Ellen Dittberner To Return As Arocell CFO On Jan 13, 2025
Brief: Labbex Förvaltnings Increases Its Ownership In Arocell
Brief: New Patent Strengthens Arocell's Intellectual Property Portfolio
Brief: AroCell Q3 EBIT Loss at SEK 10.1 Million
Brief: Max Pihlqvist Is Appointed New Chairman In AroCell